Observational studyAnnals of the American Thoracic Society2026

Long-term reductions in inflammation in people with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor.

Scott D Sagel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.